Pioglitazone - PDFSEARCH.IO - Document Search Engine

Pioglitazone
Results: 289

#	Item
81	Summary of Financial Statements for the Six Month Period Ended September 30, 2014 (IFRS, Consolidated) October 30, 2014 Takeda Pharmaceutical Company Limited Add to Reading List Source URL: www.takeda.com Language: English - Date: 2014-10-30 01:30:45 Pharmaceutical sciences Organic chemistry Takeda Pharmaceutical Company Pyridines Thiazolidinediones Pharmaceuticals policy Pharmaceutical industry Pioglitazone International Financial Reporting Standards Chemistry Pharmacology Eli Lilly and Company
82	PDF Document Add to Reading List Source URL: www.pqaalliance.org Language: English - Date: 2014-10-21 21:21:42 Anti-diabetic drugs Thiazolidinediones Eli Lilly and Company Pyridines Organofluorides Pioglitazone Metformin Anti-diabetic medication Exenatide Chemistry Organic chemistry Medicine
83	This document lists observations made by the FDA representative(s) during the inspection of your facility Add to Reading List Source URL: www.fda.gov Language: English Alcohols Euphoriants Prodrugs Food and Drug Administration Tramadol Form FDA 483 Metformin Pioglitazone Chemistry Pharmacology Medicine
84	Hypoglycemics, Thiazolidinediones (TZDs) Add to Reading List Source URL: www.hhsc.state.tx.us Language: English - Date: 2014-11-05 17:48:08 Pyridines Diabetes Endocrine system Eli Lilly and Company Guanidines Pioglitazone Rosiglitazone Anti-diabetic medication Metformin Thiazolidinediones Chemistry Organic chemistry
85	Intranet “Internal News” Posting & Leading Edge article, authored by Kathy, Dede or Rob Add to Reading List Source URL: www.astellas.com Language: English - Date: 2012-09-28 03:44:41 Health Pioglitazone Anti-diabetic medication Diabetes mellitus Insulin Glycated hemoglobin Hypoglycemia Sulfonylurea Diabetic hypoglycemia Diabetes Endocrine system Medicine
86	FDA Tentative Approval[removed]Nevirapine Tablets 200 mg Huahai Pharmaceuticals Co., Ltd. 1 Add to Reading List Source URL: apps.who.int Language: English - Date: 2009-12-08 04:14:12 Non-nucleoside reverse transcriptase inhibitors Cyclopropanes Lactams Nevirapine Eli Lilly and Company Antiretroviral drug Reverse-transcriptase inhibitor Pre-exposure prophylaxis Pioglitazone Chemistry Organic chemistry Pyridines
87	SUMMARY OF FINANCIAL STATEMENTS [IFRS] (CONSOLIDATED) Financial Results for the Fiscal Year Ended March 31, 2014 May 8, 2014 Takeda Pharmaceutical Company Limited Add to Reading List Source URL: www.takeda.com Language: English - Date: 2014-05-15 04:21:44 Financial statements Pharmacology Takeda Pharmaceutical Company Generally Accepted Accounting Principles International Financial Reporting Standards Pharmaceutical industry Pioglitazone Consolidation Pfizer Accountancy Finance Business
88	INSIDE www.healthpart.com A triannual news and information publication for participating providers SPRING/SUMMER•20I3 NETWORK MANAGEMENT Add to Reading List Source URL: www.healthpartnersplans.com Language: English - Date: 2014-01-28 12:59:39 Health economics Health informatics Eli Lilly and Company Pioglitazone Pyridines Anti-diabetic medication Metformin Medicare Health care Health Medicine Thiazolidinediones
89	Summary of Financial Statements for the Six Month Period Ended September 30, 2013 (Japan GAAP, Consolidated) October 31, 2013 Takeda Pharmaceutical Company Limited Add to Reading List Source URL: www.takeda.com Language: English - Date: 2013-10-30 23:58:40 Eli Lilly and Company Takeda Pharmaceutical Company Pyridines Thiazolidinediones Pharmaceuticals policy Pharmaceutical industry Pioglitazone International Financial Reporting Standards Food and Drug Administration Pharmaceutical sciences Chemistry Pharmacology
90	Summary of Financial Statements for the Nine Month Period Ended December 31, 2013 (Japan GAAP, Consolidated) February 5, 2014 Takeda Pharmaceutical Company Limited Add to Reading List Source URL: www.takeda.com Language: English - Date: 2014-02-04 21:55:20 Takeda Pharmaceutical Company Pyridines Thiazolidinediones Pharmacy Pharmaceutical industry Pioglitazone International Financial Reporting Standards Food and Drug Administration Financial ratio Pharmaceutical sciences Pharmacology Clinical research

UPDATE